What kinds of innovative or flexible business models do Genencor and Dow Corning have?
TP: Genencor has used a biotech business model to navigate the new opportunity space connecting our technology and competencies with new markets. This model has served well to manage the risks of new product development with the off-set of shared rewards and has allowed the heavy R&D investment required to continually expand the biotechnology expertise of the company. JMG: The key paradigm for chemical companies is that innovation has been primarily product-oriented. Dow Corning has gone beyond that, and its one of the main reasons weve been so successful. Weve been able to put our different capabilities together to create what we call innovation in channel and business models, which led to the launch of our web-based Xiameter brand. It has provided a new way to reach a certain customer segment.
